These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 1776885)

  • 1. Compliance assessed by the Medication Event Monitoring System.
    Olivieri NF; Matsui D; Hermann C; Koren G
    Arch Dis Child; 1991 Dec; 66(12):1399-402. PubMed ID: 1776885
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Critical comparison of novel and existing methods of compliance assessment during a clinical trial of an oral iron chelator.
    Matsui D; Hermann C; Klein J; Berkovitch M; Olivieri N; Koren G
    J Clin Pharmacol; 1994 Sep; 34(9):944-9. PubMed ID: 7983239
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effective chelation of iron in beta thalassaemia with the oral chelator 1,2-dimethyl-3-hydroxypyrid-4-one.
    Kontoghiorghes GJ; Aldouri MA; Hoffbrand AV; Barr J; Wonke B; Kourouclaris T; Sheppard L
    Br Med J (Clin Res Ed); 1987 Dec; 295(6612):1509-12. PubMed ID: 3122880
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Oral iron chelation with 1,2-dimethyl-3-hydroxypyrid-4-one (L1) in iron loaded thalassemia patients.
    Olivieri NF; Matsui D; Liu PP; Blendis L; Cameron R; McClelland RA; Templeton DM; Koren G
    Bone Marrow Transplant; 1993; 12 Suppl 1():9-11. PubMed ID: 8374574
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Chelation therapy in patients with thalassemia using the orally active iron chelator deferiprone (L1).
    Rombos Y; Tzanetea R; Konstantopoulos K; Simitzis S; Zervas C; Kyriaki P; Kavouklis M; Aessopos A; Sakellaropoulos N; Karagiorga M; Kalotychou V; Loukopoulos D
    Haematologica; 2000 Feb; 85(2):115-7. PubMed ID: 10681716
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Relationship between the pharmacokinetics and iron excretion pharmacodynamics of the new oral iron chelator 1,2-dimethyl-3-hydroxypyrid-4-one in patients with thalassemia.
    Matsui D; Klein J; Hermann C; Grunau V; McClelland R; Chung D; St-Louis P; Olivieri N; Koren G
    Clin Pharmacol Ther; 1991 Sep; 50(3):294-8. PubMed ID: 1914364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Comparative efficacy of desferrioxamine, deferiprone and in combination on iron chelation in thalassemic children.
    Gomber S; Saxena R; Madan N
    Indian Pediatr; 2004 Jan; 41(1):21-7. PubMed ID: 14767084
    [TBL] [Abstract][Full Text] [Related]  

  • 8. 1,2-Dimethyl-3-hydroxypyrid-4-one, an orally active chelator for treatment of iron overload.
    Kontoghiorghes GJ; Aldouri MA; Sheppard L; Hoffbrand AV
    Lancet; 1987 Jun; 1(8545):1294-5. PubMed ID: 2884415
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Combined therapy with desferrioxamine and deferiprone in beta thalassemia major patients with transfusional iron overload.
    Daar S; Pathare AV
    Ann Hematol; 2006 May; 85(5):315-9. PubMed ID: 16450126
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Iron-chelation therapy with oral deferiprone in patients with thalassemia major.
    Olivieri NF; Brittenham GM; Matsui D; Berkovitch M; Blendis LM; Cameron RG; McClelland RA; Liu PP; Templeton DM; Koren G
    N Engl J Med; 1995 Apr; 332(14):918-22. PubMed ID: 7877649
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Long-term treatment with deferiprone in a L1 veteran.
    Meo A; Ruggeri A; La Rosa MA; Zanghì L; Kordes U; Fischer R
    Eur J Haematol; 2005 Jun; 74(6):523-5. PubMed ID: 15876257
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparison of oral iron chelator L1 and desferrioxamine in iron-loaded patients.
    Olivieri NF; Koren G; Hermann C; Bentur Y; Chung D; Klein J; St Louis P; Freedman MH; McClelland RA; Templeton DM
    Lancet; 1990 Nov; 336(8726):1275-9. PubMed ID: 1978115
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combined therapy with deferiprone and desferrioxamine in thalassemia major.
    Origa R; Bina P; Agus A; Crobu G; Defraia E; Dessì C; Leoni G; Muroni PP; Galanello R
    Haematologica; 2005 Oct; 90(10):1309-14. PubMed ID: 16219566
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized controlled study evaluating the safety and efficacy of deferiprone treatment in thalassemia major patients from Hong Kong.
    Ha SY; Chik KW; Ling SC; Lee AC; Luk CW; Lam CW; Ng IO; Chan GC
    Hemoglobin; 2006; 30(2):263-74. PubMed ID: 16798652
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Objectives and mechanism of iron chelation therapy.
    Hershko C; Link G; Konijn AM; Cabantchik ZI
    Ann N Y Acad Sci; 2005; 1054():124-35. PubMed ID: 16339658
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Consequences and costs of noncompliance with iron chelation therapy in patients with transfusion-dependent thalassemia: a literature review.
    Delea TE; Edelsberg J; Sofrygin O; Thomas SK; Baladi JF; Phatak PD; Coates TD
    Transfusion; 2007 Oct; 47(10):1919-29. PubMed ID: 17880620
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Treatment of iron overload states with oral administration of the chelator agent, L1 (Deferiprone)].
    Cermák J; Brabec V
    Vnitr Lek; 1994 Sep; 40(9):586-90. PubMed ID: 7975362
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combined oral and parenteral iron chelation in beta thalassaemia major.
    Balveer K; Pyar K; Wonke B
    Med J Malaysia; 2000 Dec; 55(4):493-7. PubMed ID: 11221163
    [TBL] [Abstract][Full Text] [Related]  

  • 19. How often is medication taken as prescribed? A novel assessment technique.
    Cramer JA; Mattson RH; Prevey ML; Scheyer RD; Ouellette VL
    JAMA; 1989 Jun; 261(22):3273-7. PubMed ID: 2716163
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assessment of the effect of the oral iron chelator deferiprone on asymptomatic Plasmodium falciparum parasitemia in humans.
    Thuma PE; Olivieri NF; Mabeza GF; Biemba G; Parry D; Zulu S; Fassos FF; McClelland RA; Koren G; Brittenham GM; Gordeuk VR
    Am J Trop Med Hyg; 1998 Mar; 58(3):358-64. PubMed ID: 9546419
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.